7,717 CVS Health Corporation $CVS Shares Sold by Means Investment CO. Inc.

Means Investment CO. Inc. cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 65.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,130 shares of the pharmacy operator’s stock after selling 7,717 shares during the period. Means Investment CO. Inc.’s holdings in CVS Health were worth $354,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. bought a new stake in shares of CVS Health during the second quarter worth $12,747,462,000. State Street Corp raised its holdings in shares of CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after buying an additional 15,604,883 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the last quarter. Pzena Investment Management LLC acquired a new position in CVS Health during the 2nd quarter worth about $1,217,558,000. Finally, Wellington Management Group LLP lifted its position in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CVS shares. JPMorgan Chase & Co. increased their price objective on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. BMO Capital Markets set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Evercore reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday. Jefferies Financial Group reissued a “buy” rating and set a $103.00 price target on shares of CVS Health in a research note on Wednesday. Finally, UBS Group lowered their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating for the company in a report on Thursday. Twenty-two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $108.25.

Insider Activity

In related news, EVP Prem Shah acquired 23,855 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.85% of the stock is owned by corporate insiders.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Price Performance

CVS Health stock opened at $83.76 on Monday. The business’s 50-day simple moving average is $90.37 and its 200 day simple moving average is $88.89. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $107.17 billion, a price-to-earnings ratio of 9.75, a P/E/G ratio of 0.73 and a beta of 0.58. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. During the same period in the previous year, the business posted $1.60 EPS. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. As a group, research analysts anticipate that CVS Health Corporation will post 8.25 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. The ex-dividend date was Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is currently 30.97%.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.